[1] |
WEN Ziqiang, LAN Junliang, ZHOU Bo, XU Qiwei.
PARP1 promotes the progression of hepatocellular carcinoma by regulating expression of POU2F2
[J]. China Oncology, 2024, 34(9): 848-856.
|
[2] |
CAO Fei, YU Wenhao, TANG Xiaonan, MA Zidong, CHANG Tingmin, GONG Yabin, LIAO Mingjuan, KANG Xiaohong.
Mechanism of LINC01410 promoting proliferation and migration in esophageal squamous cell carcinoma
[J]. China Oncology, 2024, 34(8): 753-762.
|
[3] |
CHEN Xun, ZHENG Zhenxia, RUAN Xueru.
Effects of TMCO1 on proliferation and migration of cervical cancer cells
[J]. China Oncology, 2024, 34(6): 571-580.
|
[4] |
SUN Rongqi, SONG Ning, ZHENG Wentian, ZHANG Xinyue, LI Minmin, GONG Hui, JIANG Yingying.
Effect of long noncoding RNA FLJ30679 on proliferation and migration of oral squamous cell carcinoma cells
[J]. China Oncology, 2024, 34(5): 439-450.
|
[5] |
XIONG Jiayan, LEI Wei, YOU Bo, ZHANG Zhenxin, XIE Haijing, SHAN Ying, XIA Tian, ZHOU Yong.
Study on the mechanism of DDX6 promoting proliferation and migration of nasopharyngeal carcinoma cells by regulating stability of CKMT1A mRNA
[J]. China Oncology, 2024, 34(5): 451-459.
|
[6] |
ZHOU Xueqin, LUAN Yanchao, ZHAO Li, RONG Chaochao, YANG Na.
Expression of CDC20 in lung adenocarcinoma tissues and its effect on the proliferation and invasion of lung adenocarcinoma cells
[J]. China Oncology, 2024, 34(5): 460-472.
|
[7] |
GUAN Ruirui, HAO Qian, ZHANG Yaqi, SUN Qinggang, CHEN Yitian, LI Xiumin, ZHOU Xiang, HAN Tao.
CDC20 facilitates the proliferation of esophageal carcinoma cell by stabilizing NLRP3 expression
[J]. China Oncology, 2024, 34(5): 473-484.
|
[8] |
WANG Shanshan, YE Dingwei, YANG Li, CHENG Fan, YANG Tiejun, ZHANG Xiaoping, YU Zhixian, ZHANG Qingyun, YANG Yong.
Correlation of HER2 expression and clinicopathological characteristics in patients with urothelial carcinoma in China
[J]. China Oncology, 2024, 34(11): 1011-1019.
|
[9] |
XU Ziqi, HU Ruizhi, LI Junjian, WANG Hongxia, SANG Youzhou.
Exploring the role of methylation-driven gene IFFO1 in pancreatic adenocarcinoma diagnosis, prognosis and cellular functions
[J]. China Oncology, 2024, 34(11): 998-1010.
|
[10] |
ZHAO Junxiu, ZHU Yi, SONG Xiaoyu, ZHE Chao, XIAO Yuhan, LIU Yunduo, LI Linhai, XIAO Bin.
Circ-0007766 acts as a miR-1972 sponge to promote breast cancer cell migration and invasion via upregulation of HER2
[J]. China Oncology, 2024, 34(10): 915-930.
|
[11] |
JIA Liqing, GE Xiaolu, JIANG Lin, ZHOU Xiaoyan.
Effects of lncRNA PKD2-2-3 on cell proliferation, clone formation, migration, and invasion of lung adenocarcinoma
[J]. China Oncology, 2023, 33(8): 717-725.
|
[12] |
DONG Hao, QIU Yonggang, WANG Xinbin, YANG Junjie, LOU Cuncheng, YIN Lekang, YE Xiaodan.
Predictive value of logistic regression model based on high-resolution CT signs for high-grade pattern in stage ⅠA lung adenocarcinoma
[J]. China Oncology, 2023, 33(8): 768-775.
|
[13] |
KANG Yinnan, CHEN Shun, XIE Youcheng, ZHENG Ying, HE Yujing, LI Chuyi, YU Xiaohui.
Application and research progress of antibody drug conjugates in HER2 positive advanced gastric cancer
[J]. China Oncology, 2023, 33(8): 790-800.
|
[14] |
LIU Xiaoli, CHAI Wenjun, SUN Lei, YAN Mingxia, PAN Hongyu, SUN Yuexi.
Analysis of differential splicing gene by regulation of splicing regulatory protein KHSRP in lung adenocarcinoma
[J]. China Oncology, 2023, 33(7): 637-645.
|
[15] |
WANG Ruoxi, JI Peng, GONG Yue, CHEN Sheng.
Response rate and clinical outcome of HER2-low breast cancer after neoadjuvant therapy: a single-center retrospective study
[J]. China Oncology, 2023, 33(7): 686-692.
|